🔒 EFPIA report: economic impact of industry clinical trials across Europe
Industry clinical trials created €10.1 billion in direct GVA and €21.7 billion in total GVA across the EEA in 2025, accounting for indirect …
High impact 68 min
Drug profile · INN
gv-
gv- is an FDA-listed pharmaceutical active ingredient.
NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gv-
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.70
Quick answer
gv- is an FDA-listed pharmaceutical active ingredient.
Key facts
INN gv-
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Related research
🔒 Frequently asked questions
What is gv-?
gv- is an FDA-listed pharmaceutical active ingredient.